• Mtor Pathway
    • Contribution Of Ultrarare...
    • Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies: Influence Statistics

      Expert Impact

      Concepts for whichthey havehas direct influence:Mtor pathway,Pathogenic variants,Variants genes,Sclerosis complex,Tuberous sclerosis,Activating proteins,Gtpase activating,Female gtpase.

      Key People For Mtor Pathway

      Top KOLs in the world
      David M Sabatini
      mechanistic target rag gtpases amino acids
      Michael Nip Hall
      actin cytoskeleton saccharomyces cerevisiae cell growth
      Nahum Sonenberg
      translation initiation binding protein messenger rna
      Kun‐Liang Kunliang
      hippo pathway cell growth protein kinase
      Lewis C Cantley
      protein kinase phosphatidylinositol 3 cancer cells
      John Blenis
      s6 kinase cell growth ribosomal protein

      Contribution of ultrarare variants in mTOR pathway genes to sporadic focal epilepsies


      Objective: We investigated the contribution to sporadic focal epilepsies (FE) of ultrarare variants in genes coding for the components of complexes regulating mechanistic Target Of Rapamycin (mTOR)complex 1 (mTORC1).

      Methods: We collected genetic data of 121 Italian isolated FE cases and 512 controls by Whole Exome Sequencing (WES) and single-molecule Molecular Inversion Probes (smMIPs) targeting 10 genes of the GATOR1, GATOR2, and TSC complexes. We collapsed "qualifying" variants (ultrarare and predicted to be deleterious or loss of function) across the examined genes and sought to identify their enrichment in cases compared to controls.

      Results: We found eight qualifying variants in cases and nine in controls, demonstrating enrichment in FE patients (P = 0.006; exact unconditional test, one-tailed). Pathogenic variants were identified in DEPDC5 and TSC2, both major genes for Mendelian FE syndromes.

      Interpretation: Our findings support the contribution of ultrarare variants in genes in the mTOR pathway complexes GATOR and TSC to the risk of sporadic FE and a shared genetic basis between rare and common epilepsies. The identification of a monogenic etiology in isolated cases, most typically encountered in clinical practice, may offer to a broader community of patients the perspective of precision therapies directed by the underlying genetic cause.

      Sign-in to see all concepts, it's free!


    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.